CompanyScope

Teva Pharmaceutical Industries Limited 10-K and 10-Q filings

Ticker TEVA · SEC CIK 818686 · Latest fiscal year ended Dec 31, 2025

Teva Pharmaceutical Industries Limited has 17 annual reports and 27 quarterly reports with XBRL financial data on SEC EDGAR, filed between Feb 22, 2010 and Nov 3, 2026. Each link opens the filing's index page on sec.gov, where you can read the full document.

FiledFormAccession numberDocument
Nov 3, 202610-Q0000818686-26-000006View on SEC EDGAR
Jul 29, 202610-Q0001193125-26-323619View on SEC EDGAR
Apr 29, 202610-Q0001193125-26-191513View on SEC EDGAR
Feb 3, 202610-K0001193125-26-034532View on SEC EDGAR
Nov 5, 202510-Q0001193125-25-266895View on SEC EDGAR
Jul 30, 202510-Q0001193125-25-169296View on SEC EDGAR
May 7, 202510-Q0001193125-25-114889View on SEC EDGAR
Feb 5, 202510-K0001193125-25-020826View on SEC EDGAR
Nov 6, 202410-Q0001193125-24-252039View on SEC EDGAR
Jul 31, 202410-Q0001193125-24-189924View on SEC EDGAR
May 8, 202410-Q0001193125-24-134200View on SEC EDGAR
Feb 12, 202410-K0001193125-24-031005View on SEC EDGAR
Nov 9, 202310-Q0001193125-23-274495View on SEC EDGAR
Aug 2, 202310-Q0001193125-23-201707View on SEC EDGAR
May 10, 202310-Q0001193125-23-140697View on SEC EDGAR
Feb 10, 202310-K0001193125-23-031250View on SEC EDGAR
Nov 3, 202210-Q0001193125-22-276883View on SEC EDGAR
Jul 27, 202210-Q0001193125-22-203392View on SEC EDGAR
May 3, 202210-Q0001193125-22-138669View on SEC EDGAR
Feb 9, 202210-K0001193125-22-032667View on SEC EDGAR
Oct 27, 202110-Q0001193125-21-308672View on SEC EDGAR
Jul 28, 202110-Q0001193125-21-227389View on SEC EDGAR
Apr 28, 202110-Q0001193125-21-136842View on SEC EDGAR
Feb 10, 202110-K0001193125-21-036239View on SEC EDGAR
Nov 5, 202010-Q0001193125-20-286828View on SEC EDGAR
Aug 5, 202010-Q0001193125-20-210627View on SEC EDGAR
May 7, 202010-Q0001193125-20-136212View on SEC EDGAR
Feb 21, 202010-K0001193125-20-044221View on SEC EDGAR
Nov 7, 201910-Q0001193125-19-287265View on SEC EDGAR
Aug 7, 201910-Q0001193125-19-215317View on SEC EDGAR
May 2, 201910-Q0001193125-19-134970View on SEC EDGAR
Feb 19, 201910-K0001193125-19-043564View on SEC EDGAR
Nov 1, 201810-Q0001193125-18-315734View on SEC EDGAR
Aug 2, 201810-Q0001193125-18-236536View on SEC EDGAR
May 3, 201810-Q0001193125-18-150803View on SEC EDGAR
Feb 12, 201810-K0001193125-18-039076View on SEC EDGAR
Feb 15, 201720-F0001193125-17-045463View on SEC EDGAR
Feb 11, 201620-F0001193125-16-459785View on SEC EDGAR
Feb 9, 201520-F0001193125-15-039151View on SEC EDGAR
Feb 10, 201420-F0001193125-14-041871View on SEC EDGAR
Feb 12, 201320-F0001193125-13-050510View on SEC EDGAR
Feb 17, 201220-F0001193125-12-067417View on SEC EDGAR
Feb 15, 201120-F0001193125-11-036753View on SEC EDGAR
Feb 22, 201020-F0001193125-10-036435View on SEC EDGAR

This list covers filings that contain XBRL financial data (generally from 2009 onward). It does not include 8-Ks, proxy statements or other forms. For the complete history, see Teva Pharmaceutical Industries Limited on EDGAR.

Source: SEC EDGAR XBRL company facts for CIK 818686 (raw data). Most recent filing in this dataset: 10-Q filed Nov 3, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.